Innovated Product
embed video
Quick Links
Contact Us
Twitter, Inc.
ADD: El-sarag towers No.2 Entrance No4Makram Ebid St.
Tel:02 22756545 - 02 26703616
E-mail:
info@mdcegy.com
Product Details
Resolute Integrity DES
Resolute Integrity DES: The Best in Stent Innovation Unite
Resolute Integrity DES combines the powerful clinical advantages of Resolute DES with the groundbreaking continuous sinusoid technology of Integrity BMS. The result is a revolutionary new DES that provides superior deliverability1 and powerful clinical performance, making it even easier for you to address theneeds of your complex cases .
Micro Trac Delivery System Enhances Capabilities
BioLinx Polymer and Zotarolimus Drug
• BioLinx biocompatible polymer allows for rapid, complete and functional healing
Potent antiproliferative drug allows effective inhibition of neointimal growth.
Resolute IntegrityTM DES: Simplify the Challenge of Unplanned DAPT Interruption
RESOLUTE DAPT Interruption Analysis Methodology
Pooled Patient-Level Data From Over 5000 Patients
.jpg)
A robust post-hoc analysis on the high-quality RESOLUTE Pooled DAPT interruption data was performed
Every ResoluteTM DES study patient with available DAPT usage data was included
High degree of data monitoring was performed in all studies
The ST rates through one year were assessed based on
The timing of the first DAPT interruption: No interruption; 0-1 month interruption; 1-12 month interruption
The duration of the first DAPT interruption: interruption > 1 day; interruption > 14 days; permanent discontinuation
Reasons for DAPT Temporary Interruption and Discontinuation
Thienopyridine and/or Aspirin Interruption and Discontinuation
No Increased Risk of ST in ResoluteTM DES Patients Interrupting DAPT Beyond One Month
DAPT Language in Updated CE Mark IFU
Significant Statement of Finding
ResoluteTM DES Showed Low 1.1% ST Rate in More Than 5000 Patients
RESOLUTE Pooled* Stent Thrombosis Rate to 3 Years
Resolute Integrity DES Provides Superior Deliverability
Continuous Sinusoid Technology Provides a Fluid Range of Motion
Resolute Integrity DES Provides Superior Deliverability
Superior Deliverability Without Compromise
Comprehensive, Unique, Bold RESOLUTE Clinical Program
Over 5000 Resolute DES Patients Enrolled; 3489 Patients from All-Comers Trials
RESOLUTE All Comers Trial Design Large, Real-World Study That Reflects Complexities of Daily Clinical Practice
Powerful Clinical Performance Sustained Out to 4 Years
Powerful Results Sustained Out to 4 Years
No Difference in Efficacy or Safety Endpoints
No Significant Difference in ARC Definite/Probable Stent Thrombosis at 4 Years
Low Rates of Very Late Stent Thrombosis (VLST) Despite Low DAPT Rate After One Year
Maintains Powerful Performance in Complex Patients
Medtronic | Symplicity RDN - The Leader in Renal Denervation
Ardian's Catheter-Based Treatment for Hypertension
